Asset Details
Do you wish to reserve the book?
Behind Cuba's successful pandemic response
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Behind Cuba's successful pandemic response
Do you wish to request the book?
Behind Cuba's successful pandemic response
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Behind Cuba's successful pandemic response
2021
Overview
On the basis of as-yet-unpublished results from early-stage clinical trials, Vicente Verez-Bencomo, director-general of the Finlay Institute, expects the vaccine to show an efficacy in the region of 80–95%. “The international health programme is about solidarity; Cuba believes that healthy populations are the bedrock of global society and they want to support that any way they can”, said Clare Wenham, assistant professor of global health policy at the London School of Economics and Political Science (London, UK). “Health centres and clinics face regular stock outs of basic drugs, such as paracetamol, and other equipment such as bandages”, notes Fiona Samuels, senior research fellow and honorary associate professor at the London School of Hygiene & Tropical Medicine (London, UK).
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Biotechnology - organization & administration
/ Clinical Trials as Topic - economics
/ Clinical Trials as Topic - organization & administration
/ COVID-19
/ COVID-19 - prevention & control
/ desk
/ Drug Development - economics
/ Drug Development - organization & administration
/ Humans
/ Hygiene
/ Mass Vaccination - economics
/ Mass Vaccination - organization & administration
/ Pandemics - prevention & control
/ Severe acute respiratory syndrome coronavirus 2
/ Vaccines
